This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiang, Y.
Right arrow Articles by Leis, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiang, Y.
Right arrow Articles by Leis, J.

 Previous Article  |  Next Article 

Journal of Virology, July 2001, p. 6016-6021, Vol. 75, No. 13
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.13.6016-6021.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Proper Processing of Avian Sarcoma/Leukosis Virus Capsid Proteins Is Required for Infectivity

Yan Xiang,1,dagger Rebekah Thorick,1 Marcy L. Vana,1 Rebecca Craven,2 and Jonathan Leis3,*

Department of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106-49351; Pennsylvania State University College of Medicine, Hershey, Pennsylvania 170332; and Northwestern University School of Medicine, Chicago, Illinois 606113

Received 27 September 2000/Accepted 9 April 2001

The formation of the mature carboxyl terminus of CA in avian sarcoma/leukemia virus is the result of a sequence of cleavage events at three PR sites that lie between CA and NC in the Gag polyprotein. The initial cleavage forms the amino terminus of the NC protein and releases an immature CA, named CA1, with a spacer peptide at its carboxyl terminus. Cleavage of either 9 or 12 amino acids from the carboxyl terminus creates two mature CA species, named CA2 and CA3, that can be detected in avian sarcoma/leukemia virus (R. B. Pepinsky, I. A. Papayannopoulos, E. P. Chow, N. K. Krishna, R. C. Craven, and V. M. Vogt, J. Virol. 69:6430-6438, 1995). To study the importance of each of the three CA proteins, we introduced amino acid substitutions into each CA cleavage junction and studied their effects on CA processing as well as virus assembly and infectivity. Preventing cleavage at any of the three sites produced noninfectious virus. In contrast, a mutant in which cleavage at site 1 was enhanced so that particles contained CA2 and CA3 but little detectable CA1 was infectious. These results support the idea that infectivity of the virus is closely linked to proper processing of the carboxyl terminus to form two mature CA proteins.


* Corresponding author. Mailing address: Department of Microbiology and Immunology, Northwestern University School of Medicine, 303 E. Chicago Ave., Chicago, IL 60611. Phone: (312) 503-0338. Fax: (312) 503-7654. E-mail: j-leis{at}northwestern.edu.

dagger Present address: NIH/NIAID/LVD, Bethesda, MD 20892-0445.


Journal of Virology, July 2001, p. 6016-6021, Vol. 75, No. 13
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.13.6016-6021.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Keller, P. W., Johnson, M. C., Vogt, V. M. (2008). Mutations in the Spacer Peptide and Adjoining Sequences in Rous Sarcoma Virus Gag Lead to Tubular Budding. J. Virol. 82: 6788-6797 [Abstract] [Full Text]  
  • Scheifele, L. Z., Kenney, S. P., Cairns, T. M., Craven, R. C., Parent, L. J. (2007). Overlapping Roles of the Rous Sarcoma Virus Gag p10 Domain in Nuclear Export and Virion Core Morphology. J. Virol. 81: 10718-10728 [Abstract] [Full Text]  
  • Pettit, S. C., Clemente, J. C., Jeung, J. A., Dunn, B. M., Kaplan, A. H. (2005). Ordered Processing of the Human Immunodeficiency Virus Type 1 GagPol Precursor Is Influenced by the Context of the Embedded Viral Protease. J. Virol. 79: 10601-10607 [Abstract] [Full Text]  
  • Bowzard, J. B., Wills, J. W., Craven, R. C. (2001). Second-Site Suppressors of Rous Sarcoma Virus CA Mutations: Evidence for Interdomain Interactions. J. Virol. 75: 6850-6856 [Abstract] [Full Text]